What are the microbial components implicated in the pathogenesis of sepsis? Report on a symposium

被引:45
作者
Horn, DL
Morrison, DC
Opal, SM
Silverstein, R
Visvanathan, K
Zabriskie, JB
机构
[1] Rockefeller Univ, New York, NY 10021 USA
[2] Merck & Co Inc, West Point, PA USA
[3] Univ Missouri, Sch Med, Kansas City, MO 64108 USA
[4] Brown Univ, Sch Med, Providence, RI 02912 USA
[5] Univ Kansas, Med Ctr, Kansas City, KS 66103 USA
关键词
D O I
10.1086/318127
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Despite considerable efforts in the past quarter century to improve therapy for sepsis, mortality rates remain unacceptably high. Microbe-derived constituents can induce the host to produce many mediators that can contribute to immune dysregulation, tissue damage, and death. Although endotoxin-mediated events are clearly important in gram-negative infections, gram-positive bacteria can also play a dominant role. Understanding the interplay of microbial constituents and host immune or inflammatory responses prompted a meeting at Rockefeller University in May 1998, Participants discussed the relative merits of a "2-hit" hypothesis to explain the course of lethal septic shock and a "multihit" synergistic threshold hypothesis, Recommendations include the following: (I) developing animal models that closely mimic human sepsis; (2) further investigating antibiotic effects on bacteria; (3) assessing the relationships between endotoxin, prokaryotic DNA, and peptidoglycan (i.e., independent, additive, or synergistic) in inducing host responses; and (4) developing new strategies to improve outcomes. Studies are needed to better define which and how different microbial constituents lead to sepsis and to provide critical leads for therapeutic intervention.
引用
收藏
页码:851 / 858
页数:8
相关论文
共 63 条
[1]   ENDOTOXIN-MEDIATED ENDOTHELIAL-CELL INJURY AND ACTIVATION - ROLE OF SOLUBLE CD14 [J].
ARDITI, M ;
ZHOU, J ;
DORIO, R ;
RONG, GW ;
GOYERT, SM ;
KIM, KS .
INFECTION AND IMMUNITY, 1993, 61 (08) :3149-3156
[2]  
Bannan JD, 1997, ADV EXP MED BIOL, V418, P903
[3]  
Baumgartner J D, 1991, Infect Dis Clin North Am, V5, P915
[4]   IMMUNOTHERAPY OF ENDOTOXEMIA AND SEPTICEMIA [J].
BAUMGARTNER, JD ;
GLAUSER, MP .
IMMUNOBIOLOGY, 1993, 187 (3-5) :464-477
[5]  
BERMER LJ, 1997, SCIENCE, V276, P1861
[6]   A noncovalent complex vaccine prepared with detoxified Escherichia coli J5 (Rc chemotype) lipopolysaccharide and Neisseria meningitidis group B outer membrane protein produces protective antibodies against gram-negative bacteremia [J].
Bhattacharjee, AK ;
Opal, SM ;
Taylor, R ;
Naso, R ;
Semenuk, M ;
Zollinger, WD ;
Moran, EE ;
Young, L ;
Hammack, C ;
Sadoff, JC ;
Cross, AS .
JOURNAL OF INFECTIOUS DISEASES, 1996, 173 (05) :1157-1163
[7]   Superantigen and endotoxin synergize in the induction of lethal shock [J].
Blank, C ;
Luz, A ;
Bendigs, S ;
Erdmann, A ;
Wagner, H ;
Heeg, K .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1997, 27 (04) :825-833
[8]   STAPHYLOCOCCUS-MEDIATED T-CELL ACTIVATION AND SPONTANEOUS NATURAL-KILLER-CELL ACTIVITY IN THE ABSENCE OF MAJOR HISTOCOMPATIBILITY COMPLEX CLASS-II MOLECULES [J].
CHAPES, SK ;
HOYNOWSKI, SM ;
WOODS, KM ;
ARMSTRONG, JW ;
BEHARKA, AA ;
IANDOLO, JJ .
INFECTION AND IMMUNITY, 1993, 61 (09) :4013-4016
[9]   E5531, A PURE ENDOTOXIN ANTAGONIST OF HIGH POTENCY [J].
CHRIST, WJ ;
ASANO, O ;
ROBIDOUX, ALC ;
PEREZ, M ;
WANG, YA ;
DUBUC, GR ;
GAVIN, WE ;
HAWKINS, LD ;
MCGUINNESS, PD ;
MULLARKEY, MA ;
LEWIS, MD ;
KISHI, Y ;
KAWATA, T ;
BRISTOL, JR ;
ROSE, JR ;
ROSSIGNOL, DP ;
KOBAYASHI, S ;
HISHINUMA, L ;
KIMURA, A ;
ASAKAWA, N ;
KATAYAMA, K ;
YAMATSU, I .
SCIENCE, 1995, 268 (5207) :80-83
[10]   CpG oligodeoxynucleotides act as adjuvants that switch on T helper 1 (Th1) immunity [J].
Chu, RS ;
Targoni, OS ;
Krieg, AM ;
Lehmann, PV ;
Harding, CV .
JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 186 (10) :1623-1631